South Carolina Medical Cannabis Hearings: “Overwhelmingly Positive”

recreational cannabis-white house

South Carolina Medical Cannabis Hearings: Overwhelmingly Positive


On Tuesday, February 21, 2017, the South Carolina house committee will meet over whether or not there is a medical cannabis program in the state’s future. A recent poll in South Carolina (Withrop University – commissioned by the state newspaper) showed that over 75% are in favor of a medical cannabis program; however several state departments and legislators, including the state’s Governor, Henry McMaster, are actively opposing the bill. In fact, law enforcement groups and medical professionals in the state continue to refute the necessity for a medical cannabis program stating various reasons including the difficulties associated with monitoring such a program. The bill, known as the South Carolina Compassionate Care Act, includes language that the program would implement a seed-to-sale tracking system to provide transparency to the state.

While many government officials and agencies in South Carolina are still skeptical, one state Senator, Tom Davis, has been fighting for a cannabis program in the state for several years.

“It’s an issue where the politicians are a little bit behind the people, but we’re catching up,” said Davis.

With the majority of South Carolinians now in favor of a medical cannabis program, Davis has been working to develop a program that addresses the concerns of law enforcement while providing the people with accessible medical cannabis. South Carolina would be the 29th state to legalize cannabis for medical use, so Davis has a plethora of examples to cite showing how a medical cannabis program can be implemented both effectively and most importantly, safely.

“We’re not reinventing the wheel here,” Davis said. “There’s 28 other states that have done this and have told us what works, and we have an idea of what doesn’t work.”

Davis has been gathering expert testimony to present on Tuesday from law enforcement and medical professionals to patients in need of medical cannabis. Among this expert testimony includes 9 year old South Carolina resident, Mary Louise Swing, whose severe epilepsy forces her to wear sunglasses to school in order to avoid seizures that are caused by the bright fluorescent lighting. Mary’s mother, Jill, took her up to Maine over the summer where medical cannabis is legal, and brought home a new child.

“I brought home a different child than I took up there,” Swing said Thursday, adding Mary Louise was able to go outside for long walks with no severe consequences.

South Carolina legalized CBD oil for medicinal use in 2015, which has very low doses of THC, the psychoactive chemical in cannabis. Davis and Swing have been pushing for medical cannabis in the state for over 3 years.

BioTrack representatives have been present at many of the hearings leading up to Tuesday stating, “The meetings were overwhelmingly positive and informative about the state of the South Carolina cannabis industry.”


South Carolina Compassionate Care Act

Senator Optimistic About Possibility of Legalizing Medical Marijuana

South Carolina Governor Henry McMaster Says No to Medical Marijuana

South Carolina Senate Panel to Look at Pros, Cons of Medicinal Marijuana

Since 2010, BioTrack has provided the legal cannabis operators with the industries’ leading seed to sale tracking and dispensary point of sale software. Whether you operate a cultivation site, manufacturing and processing facility, medical or recreational dispensary or a business that covers the full vertical, we’ve got you covered when it comes to compliance.

Our extensive seed-to-sale software allows licensed operators to remain compliant while helping to identify key data points to streamline and optimize inventory management at each phase of the operation; cultivation, processing, destruction and waste, transportation, lab testing and dispensing.

Along with BioTrack’s best-in-class commercial software, we also provide government track and trace solutions and currently hold government contracts in nine states. This allows lawmakers and regulatory agencies to ensure a transparent and compliant program from top to bottom.

In 2021 BioTrack became a part of Forian, Inc. Forian is a Delaware corporation created by the combination of Helix Technologies, Inc. (“Helix”) and Medical Outcomes Research Analytics, LLC (“MOR”). As of March 2, 2021, each of Helix and MOR are wholly owned subsidiaries of Forian. Forian represents the unique intersection of a leading cannabis technology platform with intelligent data science yielding the combined power to drive innovation and transparency across the healthcare and cannabis industries. For more information,see our website, which remains in process.

Are you interested in learning more about BioTrack or the cannabis industry in general? Check out our careers page to learn more about what it takes to join our winning team or take a look at our industry-leading blog for great news and information about the cannabis industry.

Make sure you’re following BioTrack social media for regular news and updates. Sign up for the CannaPulse newsletter for regular updates right to your inbox!

Instagram - BioTrackTHC

Translate »